Project Grant R00GM141482

Award Date 7/15/24
Completion Date 5/31/27
Dollars Obligated $249K
Federal Grant Program
93.859
Assistance Type
Project Grant
Place of Performance
La Jolla, CA 92037, USA
Similar Awards
This $777,500 Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) is funding a research project at the University of Washington to understand the cellular mechanisms that regulate mitochondrial DNA (mtDNA) heteroplasmy and its relationship to mitochondrial quality control pathways. The key objectives are: 1) using single-cell sequencing to test hypotheses about how mitochondrial quality control...
This $420,000 federal Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) supports research to identify novel molecular mechanisms of mitochondrial dysfunction and damage in response to cellular stress. The principal investigator at Albert Einstein College of Medicine will employ an interdisciplinary approach combining advanced functional imaging, structural proteomics, and genetic modifications to...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) provides $416,250 to the University of Connecticut Health Center (UCHC) to elucidate the molecular mechanisms governing the mitochondrial stress response in human cells. The research aims to comprehensively understand how cells integrate mitochondrial stress programs to maintain a homeostatic mitochondrial network. Key objectives include...
This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS), under CFDA 93.859 Biomedical Research and Research Training program, will support a research program focused on uncovering and studying antiviral effector proteins in diverse species. The $125,000 award, effective from Sep 1, 2024 to Aug 31, 2026, will fund three key research aims: Perform structural homology searches to define patterns of gene capture in diverse viruses and identify structural...
This $999,996 Project Grant award, provided by the National Science Foundation (NSF) Biological Sciences program (CFDA 47.074), supports fundamental research aimed at generating "designer mitochondria" for biotechnology, healthcare, and basic research applications. The key objectives are to identify the factors required for human mitochondrial DNA (mtDNA) replication and characterize the mechanisms underlying the species-specificity of this process. This work represents a critical step...
This $387,783 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training Program (CFDA 93.859) supports research to uncover host-induced changes in the dynamics of pathogenic human viruses, with a focus on understanding the critical first steps of virus entry into human host cells. The research program aims to study the intrinsic dynamics of icosahedral virus particles, including enveloped RNA viruses (e.g.,...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) will support research to investigate the upstream regulation of the mitochondrial acyl carrier protein (MTACP) and its role in mitochondrial oxidative metabolism. Specifically, the research aims to determine how MTACP is activated via 4'-phosphopantetheinylation and how the acylation substrate malonyl-CoA is generated in the mitochondria....
This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) aims to study how viral pathogens hijack the cellular machinery responsible for DNA replication and repair in mammals. The $375,430 award, granted to the University of Wisconsin System, will run from September 10, 2024 through July 31, 2029. The research program seeks to develop novel tools and methodologies to better understand how...
This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS), under CFDA 93.859 Biomedical Research and Research Training program, will support a 5-year research project to investigate the biochemical mechanisms by which the enzyme viperin regulates cellular metabolic and signaling pathways as part of the antiviral immune response. The $930,232 award to the Regents of the University of Michigan, effective August 1, 2024, will fund studies to elucidate how...
This federal Project Grant award of $1,192,500 from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training Program (CFDA 93.859) will support research to study how human-relevant biology evolved through the capture of viral genes by our distant ancestors. The project, titled "HOSTS GOING VIRAL: BUILDING THE TOOLS AND SYSTEMS TO DETERMINE HOW HUMAN-RELEVANT BIOLOGY EVOLVED THROUGH THE CAPTURE OF VIRAL GENES IN OUR DISTANT...

This Project Grant award, totaling $248,999.00, was provided by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training Program (CFDA 93.859). The project aims to investigate the role of mitochondrial-endoplasmic reticulum (ER) contact sites, known as mitochondria/ER contacts (MERCs), in regulating the release of mitochondrial DNA (mtDNA) and coordinating innate immune responses to viral infections.

Specifically, the research will examine whether MERCs stimulate mtDNA release during infections by DNA viruses like herpes simplex virus-1 (HSV-1) and Epstein-Barr virus (EBV), and whether this benefits the host cell or the virus. The project will also test whether the mitochondrial protein MFN1 enhances innate immune responses to cytoplasmic DNA and RNA by interacting with the DNA sensor STING and the RNA sensor MAVS at MERCs. Additionally, the research will explore whether RNA viruses like influenza A and SARS-CoV-2 disrupt MERCs, leading to mtDNA release and improved antiviral defenses. This award, with an expected completion date of May 31, 2027, will support the primary investigator's transition to an independent research career focused on the role of mitochondria in innate immunity.

Generated 6/10/25, 4:28 AM